SCHEMBL7325653

SCHEMBL7325653

O=C(Nc1ccc(-n2nc(C(F)(F)F)cc2C(F)(F)F)cc1)c1cccc(F)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.71
TP53 P04637 4/20 0.71
SMN1; SMN2 Q16637 3/20 0.71
ORAI1 Q96D31 3/20 0.69
THRB P10828 2/20 0.64
TRPC3 Q13507 2/20 0.61
TRPC1 P48995 1/20 0.61
STIM1 Q13586 1/20 0.61
TRPC5 Q9UL62 1/20 0.58
EPHX2 P34913 3/20 0.55
NPC1 O15118 2/20 0.55
RAB9A P51151 2/20 0.55
TSHR P16473 2/20 0.55
LMNA P02545 1/20 0.54
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
CRACR2A Q9BSW2 1/20 0.51
USP2 O75604 1/20 0.51
ALDH1A1 P00352 1/20 0.51
HPGD P15428 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7323155 0.90 ORAI1 (0.71) MAPTTP53SMN1; SMN2ORAI1THRB
SCHEMBL7319394 0.89 ORAI1 (0.69) MAPTTP53SMN1; SMN2ORAI1THRB
SCHEMBL7322021 0.89 ORAI1 (0.69) MAPTTP53SMN1; SMN2ORAI1THRB
SCHEMBL7320557 0.89 ORAI1 (0.79) MAPTTP53SMN1; SMN2ORAI1THRB
SCHEMBL7325649 0.88 ORAI1 (0.68) MAPTTP53SMN1; SMN2ORAI1THRB
SCHEMBL7319452 0.88 ORAI1 (0.68) MAPTTP53SMN1; SMN2ORAI1THRB
SCHEMBL7319746 0.88 ORAI1 (0.68) MAPTTP53SMN1; SMN2ORAI1THRB
SCHEMBL7315734 0.88 ORAI1 (0.68) MAPTTP53SMN1; SMN2ORAI1THRB
SCHEMBL7319484 0.88 ORAI1 (0.68) MAPTTP53SMN1; SMN2ORAI1THRB
SCHEMBL7326877 0.88 ORAI1 (0.78) MAPTTP53SMN1; SMN2ORAI1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US claimed
EP-1068187-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 2001-01-17 EP claimed
WO-1999051580-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 1999-10-14 WO claimed
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US disclosed
EP-1068187-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 2001-01-17 EP disclosed
WO-1999051580-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 1999-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION IL5, IL2, IL4 MAPT 2674/4885TP53 1903/4885SMN1; SMN2 4665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.